Search

Revvity Inc

Chiusa

SettoreSettore sanitario

120.9 -2.37

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

120.52

Massimo

123.8

Metriche Chiave

By Trading Economics

Entrata

13M

53M

Vendite

19M

730M

P/E

Media del settore

62.606

56.597

EPS

1.41

Rendimento da dividendi

0.21

Margine di Profitto

7.329

Dipendenti

11,000

EBITDA

8.8M

189M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+1.82% upside

Dividendi

By Acuity

Rendimento da dividendi

Media del settore

0.21%

2.18%

Utili prossimi

26 ott 2026

Prossima data del Dividendo

13 nov 2026

Prossima data del' Ex Dividendo

23 ott 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

1.7B

15B

Apertura precedente

123.27

Chiusura precedente

120.9

Notizie sul Sentiment di mercato

By Acuity

13%

87%

13 / 339 Classifica in Healthcare

Revvity Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

9 set 2026, 20:07 UTC

News
Event

Revvity Inc announced its acquisition of Human Cell Design to enhance its Life Sciences portfolio. Shares are trading lower amid broader market weakness.

8 set 2026, 20:07 UTC

Revvity Inc shares are lower today, continuing a decline since Friday's close. The stock opened down and remained weak throughout the session.

4 set 2026, 19:47 UTC

News

Revvity Inc shares are lower amid mixed analyst ratings and price target adjustments. Earlier, shares pulled back from a session high during ongoing market volatility.

3 set 2026, 20:07 UTC

News

Revvity Inc shares are lower today, reaching a low of -2.18%. Analyst Catherine Ramsey Schulte raised the price target to $144.00 from $131.00.

2 set 2026, 21:02 UTC

Revvity Inc shares are higher in after-market trading, with no specific news identified. The broader market context includes a disappointing ADP employment report.

1 set 2026, 19:43 UTC

News

Revvity shares are lower as RBC Capital initiates coverage with a Sector Perform rating and a price target of $135.

31 ago 2026, 20:07 UTC

Revvity Inc shares are lower amid broader market reactions to inflation comments from Warsh at the Jackson Hole Economic Symposium.

28 ago 2026, 22:51 UTC

Revvity Inc shares are trading lower in after-market hours. No specific news was identified to explain this movement amid overall weak market performance.

27 ago 2026, 20:07 UTC

Revvity Inc shares are higher, continuing a trend of gains since Wednesday. The stock remains above its 20-day moving average with four consecutive higher closes.

26 ago 2026, 19:16 UTC

Revvity Inc shares are higher, supported by strong performance metrics and trading above the 20-day moving average. No specific news was identified for this move.

25 ago 2026, 21:02 UTC

Revvity Inc. shares are trading lower in after-market hours, despite remaining above their 20-day moving average and near the upper end of their one-month range.

24 ago 2026, 19:56 UTC

Revvity Inc. shares are lower today, having reached a session low earlier. Broader market pressures include economic concerns related to U.S.-Iran relations.

21 ago 2026, 23:51 UTC

Revvity Inc shares are trading lower in after-market hours. The decline follows a consistent downward trend since Friday's close, despite remaining above the 20-day moving average.

20 ago 2026, 22:01 UTC

Revvity Inc shares are lower in after-market trading, continuing a decline since Thursday's close, despite being above its 20-day moving average.

19 ago 2026, 23:11 UTC

Revvity Inc shares are higher in after-market trading, maintaining gains above the 20-day moving average and near the top of their one-month range.

17 ago 2026, 19:46 UTC

News

RVTY shares lower after analyst downgrades from JPMorgan, Stifel.

14 ago 2026, 20:13 UTC

Revvity Inc shares are lower in after-market trading, with no specific news driving the decline. Broader market trends include a drop in U.S. retail sales.

13 ago 2026, 19:46 UTC

News

Revvity shares are lower despite Q2 revenue and non-GAAP earnings growth. Analysts raised concerns about segment dynamics and competitive challenges following the earnings report.

12 ago 2026, 19:46 UTC

Revvity Inc shares are higher today, supported by positive market sentiment following a favorable inflation report and strong quarterly results from technology companies.

11 ago 2026, 20:13 UTC

Revvity Inc. shares are trading roughly flat after-market hours, with market sentiment influenced by expectations for the upcoming Consumer Price Index report.

10 ago 2026, 22:01 UTC

Revvity Inc shares are trading higher in after-market hours, following broader market dynamics and reduced expectations for Federal Reserve rate hikes.

7 ago 2026, 19:46 UTC

Revvity Inc shares are higher today, maintaining a position above the 20-day moving average and near the upper end of their one-month range.

6 ago 2026, 20:51 UTC

Revvity Inc shares are lower in after-market hours, with no specific news identified. The asset remains above its 20-day moving average.

5 ago 2026, 19:52 UTC

News

Revvity Inc shares are higher as Evercore ISI raises its price target to $126, supported by strong quarterly performance and increased guidance.

4 ago 2026, 19:51 UTC

Social Media
News

Revvity Inc shares are lower following second-quarter results that showed organic revenue growth of 3% and a slight miss on overall revenue estimates.

3 ago 2026, 19:44 UTC

News

Revvity Inc shares are higher ahead of tomorrow's earnings report, with analysts projecting a 3.9% revenue growth year-on-year, recovering from last year's decline.

31 lug 2026, 19:16 UTC

Revvity Inc shares are lower today amid broader market declines, influenced by rising yields and inflation concerns following a significant increase in crude oil prices.

29 lug 2026, 20:08 UTC

Revvity Inc shares are higher today, reflecting a steady upward trend amid rising oil prices and broader market influences. The stock is near its one-month range high.

28 lug 2026, 20:03 UTC

Revvity Inc shares are higher during Tuesday's session, continuing their advance since Monday's close, despite broader market weakness in Asian indices.

27 lug 2026, 21:02 UTC

Revvity Inc shares are lower in after-market hours, continuing a downward trend with three consecutive daily declines. No specific news was identified for the movement.

Confronto tra pari

Modifica del prezzo

Revvity Inc Previsione

Obiettivo di Prezzo

By TipRanks

1.82% in crescita

Previsioni per 12 mesi

Media 126.1 USD  1.82%

Alto 165 USD

Basso 110 USD

Basato su 11 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Revvity Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

11 ratings

4

Acquista

7

Mantieni

0

Vendi

Sentiment

By Acuity

13 / 339 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste molto forti

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Revvity Inc

Revvity, Inc. provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific,BoBs , chemagic, Chitas, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, explorer, Fontus, Genoglyphix, GSP, Haoyuan, IDS, IDS-i10 IDS-i10T, IDS-iSYS, iLab, iQ, JANUS, LabChip, LifeCycle, LimsLink, Migele, MultiPROBE, NEXTFLEX, NextPrep, Pannoramic, Panthera Puncher, PG-Seq, PGFind PKamp, PreNAT II, Prime, Protein Clear, ProteinEXact, QSigh, QuantiVac, RONIA, Sciclone, SimplicityChrom, Specimen Gate,Superflex, Symbio, T-SPOT, Touch, Twister, Vanadis, VariSpec, ViaCord VICTOR 2D, and Zephyr brand name. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
help-icon Live chat